J&J urges shareholders to reject Tutanota 'mini-tender' offer

[Shares Certificate]
Bluberries

* Johnson & Johnson (NYSE:JNJ [https://seekingalpha.com/symbol/JNJ]) is telling is it shareholders to turn down a mini-tender offer from Tutanota as it is well below the current share price.
* On Sept. 27, Tutanota offered to purchase up to 500K shares at $145 per share. However, the healthcare giant said that on Sept. 26, its stock price closed well above that. On Friday, shares closed at $190.72.
* "Johnson & Johnson urges investors to obtain current market quotations for their shares, to consult with their broker or financial advisor and to exercise caution with respect to Tutanota’s offer," the company said in a news release [https://seekingalpha.com/pr/20262497-johnson-and-johnson-recommends-shareholders-reject-mini-tender-offer-by-tutanota].
* The offer is set to expire on Oct. 29.

MORE ON JOHNSON & JOHNSON

* Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced [https://seekingalpha.com/article/4829076-johnson-and-johnson-safe-haven-quietly-becoming-overpriced]
* Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4825596-johnson-and-johnson-jnj-presents-at-bernstein-2nd-annual-global-healthcare-conference]
* Johnson & Johnson (JNJ) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4821640-johnson-and-johnson-jnj-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference]
* J&J reportedly in talks to buy Protagonist [https://seekingalpha.com/news/4503348-j-and-j-reportedly-in-talks-to-buy-protagonist]
* Legend Biotech, J&J ink Carvykti supply agreement [https://seekingalpha.com/news/4502499-legend-biotech-johnson-and-johnson-ink-carvykti-supply-agreement]